Achieve Life Sciences, Inc.
ACHV
$-0.10
Change (1 day)
$5.98
Year High
$3.03
Year Low
Categories
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Earnings for Achieve Life Sciences, Inc. (ACHV)
Earnings in 2023 (TTM): $-29,815,000
According to Achieve Life Sciences, Inc.'s latest financial reports the company's current earnings (TTM) are $-29,815,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Achieve Life Sciences, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-29,815,000 | $-29,815,000 |
| 2022 | $-42,350,000 | $-41,875,000 |
| 2021 | $-33,152,000 | $-32,902,000 |
| 2020 | $-14,730,000 | $-14,661,000 |
| 2019 | $-16,395,000 | $-16,141,000 |
| 2018 | $-12,687,000 | $-12,687,000 |
| 2017 | $-13,634,000 | $-10,583,000 |
| 2016 | $-20,129,000 | $-20,129,000 |
| 2015 | $-16,801,000 | $-16,801,000 |
| 2014 | $-26,240,000 | $-26,240,000 |
| 2013 | $-31,849,000 | $-31,849,000 |
| 2012 | $-21,098,000 | $-21,098,000 |
| 2011 | $-14,673,000 | $-14,673,000 |
| 2010 | $-15,584,000 | $-12,584,000 |
| 2009 | $2.47 M | $5.48 M |
| 2008 | $-10,691,000 | $-4,204,000 |
| 2007 | $-15,360,303 | $-13,063,168 |
| 2006 | $-26,399,184 | $-23,551,296 |
| 2005 | $-21,805,059 | $-21,097,017 |
| 2004 | $-16,310,592 | $-16,310,592 |
| 2003 | $-10,467,099 | $-10,467,099 |
| 2002 | $-11,737,284 | $-11,635,801 |
| 2001 | $742.18 K | $542.18 K |
| 2000 | $-2,324,376 | $-2,147,437 |
| 1999 | $430 K | $400 K |
| 1998 | $-11,170,000 | $-11,200,000 |
| 1997 | $1.1 M | $1000 K |
| 1996 | $2.2 M | $1.7 M |
| 1995 | $-5,400,000 | $-5,900,000 |
| 1994 | $-8,700,000 | $-8,900,000 |